BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 7073248)

  • 1. Intrusions as a sign of Alzheimer dementia: chemical and pathological verification.
    Fuld PA; Katzman R; Davies P; Terry RD
    Ann Neurol; 1982 Feb; 11(2):155-9. PubMed ID: 7073248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical, pathological, and neurochemical changes in dementia: a subgroup with preserved mental status and numerous neocortical plaques.
    Katzman R; Terry R; DeTeresa R; Brown T; Davies P; Fuld P; Renbing X; Peck A
    Ann Neurol; 1988 Feb; 23(2):138-44. PubMed ID: 2897823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence that transmitter-containing dystrophic neurites precede paired helical filament and Alz-50 formation within senile plaques in the amygdala of nondemented elderly and patients with Alzheimer's disease.
    Benzing WC; Ikonomovic MD; Brady DR; Mufson EJ; Armstrong DM
    J Comp Neurol; 1993 Aug; 334(2):176-91. PubMed ID: 7690048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropsychological characteristics of subjects with and without neocortical Alz-50 immunoreactivity.
    Crystal H; Davies P; Dickson D; Scicutella A; Blau A; Masur D
    Prog Clin Biol Res; 1989; 317():165-73. PubMed ID: 2602414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Verbal intrusions precede memory decline in adults with Down syndrome.
    Kittler P; Krinsky-McHale SJ; Devenny DA
    J Intellect Disabil Res; 2006 Jan; 50(Pt 1):1-10. PubMed ID: 16316425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parkinson disease, dementia, and Alzheimer disease: clinicopathological correlations.
    Boller F; Mizutani T; Roessmann U; Gambetti P
    Ann Neurol; 1980 Apr; 7(4):329-35. PubMed ID: 7377758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Frontal dementia or dementia praecox? A case report of a psychotic disorder with a severe decline].
    Vanderzeypen F; Bier JC; Genevrois C; Mendlewicz J; Lotstra F
    Encephale; 2003; 29(2):172-80. PubMed ID: 14567169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Senile dementia and its borderlands.
    Roth M
    Proc Annu Meet Am Psychopathol Assoc; 1980; 69():205-32. PubMed ID: 6997868
    [No Abstract]   [Full Text] [Related]  

  • 9. In vivo proton magnetic resonance spectroscopy of the temporal lobe in Alzheimer's disease.
    Frederick BD; Lyoo IK; Satlin A; Ahn KH; Kim MJ; Yurgelun-Todd DA; Cohen BM; Renshaw PF
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Dec; 28(8):1313-22. PubMed ID: 15588758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conversion of amnestic Mild Cognitive Impairment to dementia of Alzheimer type is independent to memory deterioration.
    Rozzini L; Chilovi BV; Conti M; Bertoletti E; Delrio I; Trabucchi M; Padovani A
    Int J Geriatr Psychiatry; 2007 Dec; 22(12):1217-22. PubMed ID: 17562522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Validation of the Short Cognitive Battery (B2C). Value in screening for Alzheimer's disease and depressive disorders in psychiatric practice].
    Robert PH; Schuck S; Dubois B; Lépine JP; Gallarda T; Olié JP; Goni S; Troy S
    Encephale; 2003; 29(3 Pt 1):266-72. PubMed ID: 12876552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A case of atypical senile dementia of Alzheimer type].
    Ikeda K; Kondo H; Fujishima T; Kase K; Mizutani Y
    No To Shinkei; 1993 May; 45(5):455-60. PubMed ID: 8343297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subcortical dementia: a clinical approach.
    Benson DF
    Adv Neurol; 1983; 38():185-94. PubMed ID: 6351559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mild cognitive impairment: a risk indicator of later dementia, or a preclinical phase of the disease?
    Guarch J; Marcos T; Salamero M; Gastó C; Blesa R
    Int J Geriatr Psychiatry; 2008 Mar; 23(3):257-65. PubMed ID: 17668419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurochemical approaches to the treatment of senile dementia.
    Growdon JH; Corkin S
    Proc Annu Meet Am Psychopathol Assoc; 1980; 69():281-96. PubMed ID: 7413654
    [No Abstract]   [Full Text] [Related]  

  • 16. Absence of cholinergic deficits in "pure" vascular dementia.
    Perry E; Ziabreva I; Perry R; Aarsland D; Ballard C
    Neurology; 2005 Jan; 64(1):132-3. PubMed ID: 15642917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathological verification of ischemic score in differentiation of dementias.
    Rosen WG; Terry RD; Fuld PA; Katzman R; Peck A
    Ann Neurol; 1980 May; 7(5):486-8. PubMed ID: 7396427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dissociation of neuropathology from severity of dementia in late-onset Alzheimer disease.
    Prohovnik I; Perl DP; Davis KL; Libow L; Lesser G; Haroutunian V
    Neurology; 2006 Jan; 66(1):49-55. PubMed ID: 16401845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clusters of cognitive and behavioral disorders clearly distinguish primary progressive aphasia from frontal lobe dementia, and Alzheimer's disease.
    Marra C; Quaranta D; Zinno M; Misciagna S; Bizzarro A; Masullo C; Daniele A; Gainotti G
    Dement Geriatr Cogn Disord; 2007; 24(5):317-26. PubMed ID: 17851236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cholinergic system in Alzheimer's disease and dementia with Lewy bodies: from animal models to neuropathological data.
    Liberini P
    Funct Neurol; 1997; 12(3-4):153-7. PubMed ID: 9218969
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.